Spandan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.00 M
as on 12-12-2024
- Revenue %
(FY 2020)
- Profit 87.50%
(FY 2020)
- Ebitda 87.50%
(FY 2020)
- Net Worth -18.75%
(FY 2020)
- Total Assets %
(FY 2020)
About Spandan Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Deepak Katke, Kamal Katke, Surya Bhandari, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2014PTC258887
- Company No.
258887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2014
- Date of AGM
29 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Spandan Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaisen Lokhande  | Director | 27-Oct-2014 | Current |
| Deepak Katke | Director | 27-Oct-2014 | Current |
| Kamal Katke | Director | 27-Oct-2014 | Current |
| Surya Bhandari | Director | 27-Oct-2014 | Current |
| Krushna Adsul | Director | 20-Jul-2015 | Current |
Financial Performance of Spandan Laboratories.
Spandan Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 87.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spandan Laboratories?
In 2020, Spandan Laboratories had a promoter holding of 82.00% and a public holding of 18.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oracle Medicare Private LimitedActive 9 years 3 monthsDeepak Katke and Surya Bhandari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Thane Bharat Sahakari Bank Limited Creation Date: 28 Dec 2015 | ₹3.00 M | Open |
How Many Employees Work at Spandan Laboratories?
Unlock and access historical data on people associated with Spandan Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spandan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spandan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
